News

February 20, 2019 - Covenant Children’s introduces new ScriptCenter technology Read More

February 10, 2019 - Lineagen and PWNHealth Partner to Expand Access to Genetic Testing Solutions for the Autism Spectrum Disorder and Neurodevelopmental Disorder Communities Read More

January 29, 2019 - Viacyte Announces New Board Member Read More

January 22, 2019 - Medical Center Pharmacy Launches ScriptCenter at PATH Read More

December 17, 2018 - DalCor Announced the Completion of Patient Enrollment in the Dal-GenE, the First Phase 3 Precision Medicine Cardiovasculardisease. Read More

December 17, 2018 - Center for Beta Cell Therapy in Diabetes and ViaCyte Announce Start of European Clinical Trial of Human Stem Cell-derived Implants in Type 1 Diabetes Patients Read More

December 17, 2018 - ViaCyte Provides Update on Patent Portfolio in Stem Cell-Derived Cell Replacement Therapies for Type 1 Diabetes and Other Indications Read More

December 7, 2018 - DalCor Announced the Aappointment of Peter Schuepbach as Vice President of Technical Operations Read More

November 28, 2018 - ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes Read More

November 19, 2018 - CQDM, Diazon, the Oncopole in Collaboration with Mitacs Announce the Creation of a Prize of Excellence for Graduate Students in Cancer Research In Memory of Professor Gordon Shore Read More